Clinical Trial Update: A Phase 2 in Adult Subjects With Hereditary Angioedema [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in adults with hereditary angioedema is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Snippet

Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. | Conditions: Hereditary Angioedema (HAE) | Phase 2 | Status: ACTIVE_NOT_RECRUITING